MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results

Go back to MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results

MannKind (MNKD) PT Raised to $6.50 at Oppenheimer

February 27, 2023 9:27 AM EST

Oppenheimer analyst Steven Lichtman raised the price target on MannKind (NASDAQ: MNKD) to $6.50 (from $5.50) while maintaining a Outperform rating.

The analyst commented, "MNKD's 4Q22 sales were led by the second full quarter of Tyvaso DPI royalty; up to $9M from $6M in... More

MannKind (MNKD) Misses Q4 EPS by 2c

February 23, 2023 4:49 PM EST

MannKind (NASDAQ: MNKD) reported Q4 EPS of ($0.07), $0.02 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $36.06 million versus the consensus estimate of $35.22 million.

For earnings history and earnings-related data on MannKind (MNKD) click here.

... More